New bladder cancer therapy shows promise in Mid-Stage trial
Disease control
Recruiting now
This study tests an experimental drug called cretostimogene grenadenorepvec in people with high-risk non-muscle-invasive bladder cancer that hasn't spread into the bladder muscle. The trial includes 325 participants who have either not received prior BCG therapy or have been expo…
Phase: PHASE2 • Sponsor: CG Oncology, Inc. • Aim: Disease control
Last updated May 04, 2026 16:32 UTC